Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noemi B A Roy

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
British Journal of Haematology|May 27, 2005
Childhood essential thrombocythaemiaNoemi B A Roy, Marilyn Treacy, Peter Kench
British Journal of Haematology|February 21, 2022
Expanded eligibility for emerging therapies in sickle cell disease in the UK - crizanlizumab and voxelotorSona M Vora, Stephen Boyd, Nicholas Denny, et al.
British Journal of Haematology|December 6, 2008
The role of X-inactivation in the gender bias of patients with acquired alpha-thalassaemia and myelodysplastic syndrome (ATMDS)Peter S Haas, Noemi B A Roy, Richard J Gibbons, et al.
Haematologica|October 4, 2024
Temporal changes in erythroid progenitors in critically ill patients: a prospective cohort studyCaroline Scott, Isabella Dale-Harris, Andrew E Armitage, et al.
Nature Communications|April 19, 2023
Direct correction of haemoglobin E β-thalassaemia using base editorsMohsin Badat, Ayesha Ejaz, Peng Hua, et al.
Blood Global Hematology|February 25, 2026
Urinary carbonic anhydrase 1 excretion is a marker of hemolysis-triggering conditions suitable for point-of-care testingAlzbeta Hulikova, Zhenyi Wang, Helen Broomfield, et al.
Journal of the Intensive Care Society|November 17, 2025
Anaemia management with red blood cell transfusion to improve post-intensive care disability: Protocol for the ABC post-ICU randomised controlled trialTimothy S Walsh, Lydia Emerson, Jo Singleton, et al.
Haematologica|October 30, 2020
Recapitulation of erythropoiesis in congenital dyserythropoietic anaemia type I (CDA-I) identifies defects in differentiation and nucleolar abnormalitiesCaroline Scott, Damien J Downes, Jill M Brown, et al.
British Journal of Haematology|May 29, 2024
Pyruvate kinase deficiency in 29 Turkish patients with two novel intronic variantsVeysel Gök, Göksel Leblebisatan, Dilek Gürlek Gökçebay, et al.
Nature|June 26, 2020
Whole-genome sequencing of patients with rare diseases in a national health systemErnest Turro, William J Astle, Karyn Megy, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
British Journal of Haematology|May 27, 2005
Childhood essential thrombocythaemiaNoemi B A Roy, Marilyn Treacy, Peter Kench
British Journal of Haematology|February 21, 2022
Expanded eligibility for emerging therapies in sickle cell disease in the UK - crizanlizumab and voxelotorSona M Vora, Stephen Boyd, Nicholas Denny, et al.
British Journal of Haematology|December 6, 2008
The role of X-inactivation in the gender bias of patients with acquired alpha-thalassaemia and myelodysplastic syndrome (ATMDS)Peter S Haas, Noemi B A Roy, Richard J Gibbons, et al.
Haematologica|October 4, 2024
Temporal changes in erythroid progenitors in critically ill patients: a prospective cohort studyCaroline Scott, Isabella Dale-Harris, Andrew E Armitage, et al.
Nature Communications|April 19, 2023
Direct correction of haemoglobin E β-thalassaemia using base editorsMohsin Badat, Ayesha Ejaz, Peng Hua, et al.
Blood Global Hematology|February 25, 2026
Urinary carbonic anhydrase 1 excretion is a marker of hemolysis-triggering conditions suitable for point-of-care testingAlzbeta Hulikova, Zhenyi Wang, Helen Broomfield, et al.
Journal of the Intensive Care Society|November 17, 2025
Anaemia management with red blood cell transfusion to improve post-intensive care disability: Protocol for the ABC post-ICU randomised controlled trialTimothy S Walsh, Lydia Emerson, Jo Singleton, et al.
Haematologica|October 30, 2020
Recapitulation of erythropoiesis in congenital dyserythropoietic anaemia type I (CDA-I) identifies defects in differentiation and nucleolar abnormalitiesCaroline Scott, Damien J Downes, Jill M Brown, et al.
British Journal of Haematology|May 29, 2024
Pyruvate kinase deficiency in 29 Turkish patients with two novel intronic variantsVeysel Gök, Göksel Leblebisatan, Dilek Gürlek Gökçebay, et al.
Nature|June 26, 2020
Whole-genome sequencing of patients with rare diseases in a national health systemErnest Turro, William J Astle, Karyn Megy, et al.
Pageof 2